JPS52102419A - Lactic acid producing bacillus preparation - Google Patents

Lactic acid producing bacillus preparation

Info

Publication number
JPS52102419A
JPS52102419A JP1922676A JP1922676A JPS52102419A JP S52102419 A JPS52102419 A JP S52102419A JP 1922676 A JP1922676 A JP 1922676A JP 1922676 A JP1922676 A JP 1922676A JP S52102419 A JPS52102419 A JP S52102419A
Authority
JP
Japan
Prior art keywords
present
preparation
pathogenic
lactobacillus
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1922676A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6234731B2 (enExample
Inventor
Kousei Hata
Tadatsugu Hata
Toshiyuki Maruoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikenkai
Original Assignee
Seikenkai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikenkai filed Critical Seikenkai
Priority to JP1922676A priority Critical patent/JPS52102419A/ja
Publication of JPS52102419A publication Critical patent/JPS52102419A/ja
Priority to US06/085,349 priority patent/US4314995A/en
Publication of JPS6234731B2 publication Critical patent/JPS6234731B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP1922676A 1976-02-23 1976-02-23 Lactic acid producing bacillus preparation Granted JPS52102419A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP1922676A JPS52102419A (en) 1976-02-23 1976-02-23 Lactic acid producing bacillus preparation
US06/085,349 US4314995A (en) 1976-02-23 1979-10-16 Pharmaceutical lactobacillus preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1922676A JPS52102419A (en) 1976-02-23 1976-02-23 Lactic acid producing bacillus preparation

Publications (2)

Publication Number Publication Date
JPS52102419A true JPS52102419A (en) 1977-08-27
JPS6234731B2 JPS6234731B2 (enExample) 1987-07-28

Family

ID=11993451

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1922676A Granted JPS52102419A (en) 1976-02-23 1976-02-23 Lactic acid producing bacillus preparation

Country Status (2)

Country Link
US (1) US4314995A (enExample)
JP (1) JPS52102419A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238478A (en) * 1977-12-23 1980-12-09 Ljubinko Stojkovic Heterovaccine against the trichomonas syndrome, and process for its preparation
WO2005012503A1 (ja) * 2003-07-30 2005-02-10 Bhph Company Limited 新規乳酸菌並びに生体賦活型乳酸菌製剤及び生体に対する感染症の予防剤と治療剤

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5911177A (ja) * 1982-07-12 1984-01-20 Seikenkai 新規乳酸桿菌
US5135739A (en) * 1983-02-15 1992-08-04 Kitasato Kenkyusho Non-cariogenic composition and drink
JPS60149527A (ja) * 1984-01-17 1985-08-07 Seikenkai 生体内脱臭剤
SE463598B (sv) * 1984-11-08 1990-12-17 Chemical Dynamics Sweden Ab Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
WO1991005850A1 (fr) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Souche de bacterie de lactobacillus plantarum 38 de production d'une preparation biologique bacterienne
WO1991005852A1 (fr) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Souche de bacterie de lactobacillus fermentum 39 de production d'une preparation biologique bacterienne
US5458875A (en) * 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
WO1992012638A1 (en) * 1991-01-28 1992-08-06 Biogaia Biolog Ab METHOD FOR DELIVERING DIRECT FEED MICROORGANISMS TO POULTRY $i(IN OVO)
WO1993002558A1 (en) * 1991-08-01 1993-02-18 Biogaia Biologics Ab Method and formulation for reducing microbial populations
EP0577903B1 (fr) * 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite
ATE153063T1 (de) * 1992-07-06 1997-05-15 Nestle Sa Milchbakterien
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
US6156320A (en) * 1993-02-05 2000-12-05 Harry Parsekian Fermented milk nutraceuticals
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
ATE493139T1 (de) * 1997-04-18 2011-01-15 Ganeden Biotech Inc Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
EP1117414A1 (en) * 1998-10-01 2001-07-25 Probi Ab Reduction of oxidative stress factors
JP4193269B2 (ja) 1999-03-04 2008-12-10 ビーエイチピーエイチ カンパニーリミテッド 新規な生体浄化活性型乳酸菌製剤
US6767537B2 (en) * 2000-05-26 2004-07-27 Phil Arnold Nicolay Composition and method for the treatment of sinusitis
BR0116349A (pt) 2000-12-18 2003-12-23 Probiohealth Llc Compostos probióticos derivados da cepa ke01 de lactobacillus casei
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
JP2005192950A (ja) * 2004-01-09 2005-07-21 Ajinomoto Co Inc 微生物乾燥菌体を有効成分とする脱臭剤及び脱臭方法
US20060003454A1 (en) * 2004-07-02 2006-01-05 Conjugon, Inc. Non-dividing donor cells for gene transfer
US20060270040A1 (en) * 2005-05-26 2006-11-30 Conjugon, Inc. Compositions and methods for treating tissue
AU2006253006B8 (en) * 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
CA2607949C (en) * 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
US20070286813A1 (en) * 2006-06-09 2007-12-13 Toutounghi Camille Nasal formulation
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2015061789A2 (en) 2013-10-25 2015-04-30 Nch Corporation Delivery system and probiotic composition for animals and plants
DK3060225T3 (da) * 2013-10-25 2024-07-01 Nch Corp Leveringssystem og probiotisk sammensætning til dyr
US10766799B2 (en) 2014-05-23 2020-09-08 Nch Corporation Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
WO2019169179A1 (en) * 2018-02-28 2019-09-06 Shafer Kim Augmenting efficacy of cancer therapies using probiotic based compositions
US11401500B2 (en) 2018-08-29 2022-08-02 Nch Corporation System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications
US11576937B2 (en) 2020-02-06 2023-02-14 Nch Corporation Method of reducing gut inflammation reduction in humans by consuming a heated probiotic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1729752A (en) * 1926-02-23 1929-10-01 George T Southgate Deodorant composition
US2027374A (en) * 1932-05-03 1936-01-14 Ora S Fowler Mouth treating composition
US2944941A (en) * 1957-12-23 1960-07-12 Vaxico Inc Method and dentifrice for reducing gingival inflammation
FR1185M (fr) * 1961-03-03 1962-03-19 Ile De Rech S Scient Et Ind So Médicament a base de colibacilles non pathogenes vivants.
FR3626M (fr) * 1963-11-13 1965-10-18 Lucien Nouvel Médicament pour affections intestinales.
DK127268A (enExample) * 1970-01-12 1900-01-01
US3957974A (en) * 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238478A (en) * 1977-12-23 1980-12-09 Ljubinko Stojkovic Heterovaccine against the trichomonas syndrome, and process for its preparation
WO2005012503A1 (ja) * 2003-07-30 2005-02-10 Bhph Company Limited 新規乳酸菌並びに生体賦活型乳酸菌製剤及び生体に対する感染症の予防剤と治療剤
JPWO2005012503A1 (ja) * 2003-07-30 2007-09-27 ビーエイチピーエイチ カンパニーリミテッド 新規乳酸菌並びに生体賦活型乳酸菌製剤及び生体に対する感染症の予防剤と治療剤
US7863033B2 (en) 2003-07-30 2011-01-04 Bhph Company Limited Lactobacillus living body activating Lactobacillus preparation and preventive or therapeutic agent for living body infection
JP4661593B2 (ja) * 2003-07-30 2011-03-30 ビーエイチピーエイチ カンパニーリミテッド 新規乳酸菌並びに生体賦活型乳酸菌製剤及び生体に対する感染症の予防剤と治療剤

Also Published As

Publication number Publication date
US4314995A (en) 1982-02-09
JPS6234731B2 (enExample) 1987-07-28

Similar Documents

Publication Publication Date Title
JPS52102419A (en) Lactic acid producing bacillus preparation
ES2114565T3 (es) Lactobacilos colonizadores del intestino.
Rebora et al. Experimental infection with Candida albicans
ATE95060T1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
CA2283280A1 (en) Reovirus for the treatment of neoplasia
IL137848A0 (en) Indole-3-propionic acids, salts and esters thereof used as medicaments
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
ATE243030T1 (de) Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
MX9300131A (es) Agente probiotico, alimentos para animales que lo contienen y metodo para preparar dichos alimentos.
ES8700938A1 (es) Procedimiento para aumentar la adherencia de las bacterias en el estomago e intestinos de seres humanos y animales
ES2002398A6 (es) Procedimiento para preparar nuevas enolamidas
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
CN115607577A (zh) 一种具有缓解口腔炎症功效的益生菌剂及其制备方法和应用
Sacsaquispe-Contreras Development of new experimental dentifrice of Peruvian Solanum tuberosum (Tocosh) fermented by water stress: Antibacterial and cytotoxic activity
DE3887686D1 (de) Bakterielle zubereitung für die prophylaxe und behandlung von entzuendungen und allergischen beschwerden.
FR2333807A1 (fr) Nouveaux derives d'acide fusidique, utiles notamment comme antibacterien en medecine humaine et veterinaire et leur procede de preparation
KR910000146A (ko) 동결- 건조된 조성물 및 그 제조 방법
SE9704584L (sv) Framställning av konjugerad linolsyra
Winickoff et al. Urine culture after treatment of uncomplicated cystitis in women
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
ES440525A1 (es) Un proceso para la produccion de una sustancia sf-837 m1, de9,3",4"-trialcanoilo.
ES8304058A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10,14-hexadecapentaenoico.
Björnberg et al. Persistent pustulosis in children adopted from Asia: a sequela of scabies?
KR101731569B1 (ko) 으름덩굴 추출물을 유효성분으로 포함하는 구강세균 독성에 의한 염증을 예방, 개선 또는 치료하는 조성물
Fuller et al. Aortic connective tissue changes in miniature pigs fed a lipid-rich diet